BioSpace News Archive

Diplomat Pharmacy, Inc. (NYSE: DPLO), is now shipping temperature-sensitive medication in ClimaCell™ coolers from TemperPack.

Acquisition to Augment Diabetes Capabilities with Nutritional Database and Data Science

Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the following conferences

Healthcare Trust of America, Inc. is proud to be a Platinum sponsor of Boston Children’s Hospital’s (BCH) twenty-first annual Champions for Children’s Gala.

DexCom, Inc. announced today that it intends to offer, subject to market conditions and other factors, $750 million aggregate principal amount of Convertible Senior Notes due 2023 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).

Navidea Biopharmaceuticals, Inc. today announced the appointment of Kathy Rouan, PhD, to the Company’s board of directors, effective December 1, 2018.

Bristol-Myers Squibb Company today announced that the Phase 3 CheckMate -451 study did not meet its primary endpoint of overall survival (OS) with Opdivo (nivolumab) 1 mg/kg in combination with Yervoy (ipilimumab) 3 mg/kg versus placebo as a maintenance therapy for patients with extensive-stage small cell lung cancer (SCLC) without disease progression after completion of first-line platinum-based chemotherapy.

The effect of small-area-based SES variables is in line with patient-specific individual SES information.

Dr. Foye Ikyaator, the youngest doctor to open an ER in Texas, and her husband, Orseer Ikyaator of Houston TX opens a medspa and family practice—Foye MD and Spa, and second location of Life Savers Emergency Room.

Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement in response to the Administration’s proposed Medicare Part D rule